Hepatitis C virus-mediated inhibition of cathepsin S increases invariant-chain expression on hepatocyte surface

Journal of Virology

Volumn 86, Issue 18, 2012, Pages 9919-9928

  Kim, Hangeun ^a   Mazumdar, Budhaditya ^a   Bose, Sandip K ^a   Meyer, Keith ^a   Di Bisceglie, Adrian M ^a   Hoft, Daniel F ^a   Ray, Ranjit ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN S; HLA DR ANTIGEN; INTERFERON REGULATORY FACTOR 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NONSTRUCTURAL PROTEIN 5A; UPSTREAM STIMULATORY FACTOR 1; VIRUS PROTEIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL SURFACE; CLINICAL ARTICLE; DENDRITIC CELL; DOWN REGULATION; ENZYME INHIBITION; ENZYME SYNTHESIS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRAL CLEARANCE; VIRUS CELL INTERACTION;

ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CATHEPSINS; CELL DIFFERENTIATION; CELL LINE; CELL MEMBRANE; DENDRITIC CELLS; DOWN-REGULATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON REGULATORY FACTOR-1; TRANSFECTION; UPSTREAM STIMULATORY FACTORS; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 84866184701     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00388-12     Document Type: Article

References (45)

1. Ait-Goughoulte M, et al. 2010. Hepatitis C virus core protein interacts with fibrinogen-beta and attenuates cytokine stimulated acute-phase response. Hepatology 51:1505-1513.
2. Auffermann-Gretzinger S, Keeffe EB, Levy S. 2001. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97:3171-3176.
3. Bain C, et al. 2001. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120:512-524.
4. Banerjee A, et al. 2011. Transcriptional repression of C4 complement by hepatitis C virus proteins. J. Virol. 85:4157-4166.
5. Banerjee A, Meyer K, Mazumdar B, Ray RB, Ray R. 2010. Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression. J. Virol. 84:5936-5946.
6. Banerjee S, et al. 2008. Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream Akt/protein kinase B signaling pathway for insulin resistance. J. Virol. 82:2606-2612.
7. Bania J, et al. 2003. Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs. Proc. Natl. Acad. Sci. U. S. A. 100:6664-6669.
8. Basu A, et al. 2006. Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. Virology 349:347-358.
9. Basu A, Meyer K, Ray RB, Ray R. 2001. Hepatitis C virus core protein modulates the interferon induced transacting factors of JAK/STAT signaling pathway but does not affect the activation of interferon-stimulated genes. Virology 288:379-390.
10. Beers C, et al. 2005. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo. J. Immunol. 174:1205-1212.
11. Bell D, Young JW, Banchereau J. 1999. Dendritic cells. Adv. Immunol. 72:255-324.
12. Chan LLY, Cheung BKW, Li JCB, Lau ASY. 2010. A role for STAT3 and cathepsin S in IL-10 down-regulation of IFN-γ-induced MHC class II molecules on primary human blood macrophages. J. Leukoc. Biol. 88:303-311.
13. Chapman HA. 2006. Endosomal proteases in antigen presentation. Curr. Opin. Immunol. 18:78-84.
14. Chiu JH, et al. 1997. Class I and class II major histocompatibility complex antigens expression on human hepatocytes and hepatoma cells: an approach with high sensitivity and specificity. Cytometry 30:317-323.
15. Ciccaglione AR, et al. 2007. Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes. J. Virol. 81:202-214.
16. Cresswell P. 1998. Proteases, processing, and thymic selection. Science 280:394-395.
17. Dienes HP, Hütteroth T, Hess G, Meuer SC. 1987. Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, non-B. Hepatology 7:1317-1325.
18. Dyggve H, et al. 2011. Association of Doberman hepatitis to canine major histocompatibility complex II. Tissue Antigens 77:30-35.
19. Franco A, et al. 1988. Expression of class I and class II major histocompatibility complex antigens on human hepatocytes. Hepatology 8:449-454.
20. Gehring AJ, et al. 2007. The level of viral antigen presented by hepatocytes influences CD8 T-cell function. J. Virol. 81:2940-2949.
21. Goutagny N, et al. 2003. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J. Infect. Dis. 187:1951-1958.
22. Heath WR, Carbone FR. 2001. Cross-presentation in viral immunity and self-tolerance. Nat. Rev. Immunol. 1:126-134.
23. Hegde NR, Chevalier MS, Johnson DC. 2003. Viral inhibition of MHC class II antigen presentation. Trends Immunol. 24:278-285.
24. Henne C, Schwenk F, Koch N, Moller P. 1995. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens. Immunology 84:177-182.
25. Herkel J, et al. 2003. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocytes. Hepatology 37:1079-1085.
26. Hu KQ, Vierling JM, Siddiqui A. 1990. Trans-activation of HLA-DR gene by hepatitis B virus X gene product. Proc. Natl. Acad. Sci. U. S. A. 87:7140-7144.
27. Kanazawa N, et al. 2004. Regulation of hepatitis C virus replication by interferon regulatory factor 1. J. Virol. 78:9713-9720.
28. Kanda T, et al. 2006. Generation of infectious hepatitis C virus in immortalized human hepatocytes. J. Virol. 80:4633-4639.
29. Kanda T, Steele R, Ray R, Ray RB. 2009. Inhibition of intrahepatic gamma interferon production by hepatitis C virus nonstructural protein 5A in transgenic mice. J. Virol. 83:8463-8469.
30. Kanto T, et al. 1999. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J. Immunol. 162:5584-5591.
31. Moldenhauer G, Henne C, Karhausen J, Möller P. 1999. Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments. Immunology 96:473-484.
32. Navas MC, Fuchs AE, Schvoerer Bohbot A, Aubertin AM, Stoll-Keller F. 2002. Dendritic cell susceptibility to hepatitis C virus genotype 1 infection. J. Med. Virol. 67:152-161.
33. Osna NA. 2009. Hepatitis C virus and ethanol alter antigen presentation in liver cells. World J. Gastroenterol. 15:1201-1208.
34. Pachiadakis I, Pollara G, Chain BM, Naoumov NV. 2005. Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? Lancet Infect. Dis. 5:296-304.
35. Pflugheber J, et al. 2002 Regulation of PKR and IRF-1 during hepatitis C virus RNA replication. Proc. Natl. Acad. Sci. U. S. A. 99:4650-4655.
36. Pham TN, et al. 2004. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J. Virol. 78:5867-5874.
37. Saito K, et al. 2008. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation and induces IL-10 production. J. Virol. 82:3320-3328.
38. Scheuer PJ. 1991. Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 13:372-374.
39. Speeti M, Ståhls A, Meri S, Westermarck E. 2003. Upregulation of major histocompatibility complex class II antigens in hepatocytes in Doberman hepatitis. Vet. Immunol. Immunopathol. 96:1-12.
40. Stribling R, Sussman N, Vierling JM. 2006. Treatment of hepatitis C infection. Gastroenterol. Clin. North Am. 35:463-486.
41. Thurmond RL, Sun S, Karlsson L, Edwards JP. 2005. Cathepsin S inhibitors as novel immunomodulators. Curr. Opin. Investig. Drugs 6:473-482.
42. van's Gravesande KS, et al. 2002. IFN regulatory factor-1 regulates IFN-γ-dependent cathepsin S expression. J. Immunol. 168:4488-4494.
43. Wang Y, et al. 2006. PU. 1 regulates cathepsin S expression in professional APCs. J. Immunol. 176:275-283.
44. Wiegard C, et al. 2007. Defective T helper response of hepatocytes-stimulated CD4T cells impairs antiviral CD8 response and viral clearance. Gastroenterology 133:2010-2018.
45. Zimmermann M, et al. 2008. Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes. J. Hepatol. 48:51-61.